Presentation Impact of Wait Times on the Effectiveness of TAVR in Severe Aortic Valve Disease Presenter: Harindra C. Wijeysundera June 09, 2014 REGISTER for free or LOG IN to view this content Aortic Valve Factoid Up Next Presentation Early Regression of Severe LV Hypertrophy After TAVR Is Associated with Decreased Hospitalizations Presenter: Brian R. Lindman June 25, 2014 More slides + Presentation PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy Presenter: David R. Holmes Jr. June 30, 2014 Presentation Three-Year Outcomes after TAVR with the CoreValve Prosthesis Presenter: Michael Gotzmann June 30, 2014 We Recommend
Presentation Early Regression of Severe LV Hypertrophy After TAVR Is Associated with Decreased Hospitalizations Presenter: Brian R. Lindman June 25, 2014
Presentation PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy Presenter: David R. Holmes Jr. June 30, 2014
Presentation Three-Year Outcomes after TAVR with the CoreValve Prosthesis Presenter: Michael Gotzmann June 30, 2014